Share
Market Research Report

THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Drug ClassTherapeutic Proteins (Growth Factors, Fusion Proteins, Monoclonal Antibodies, Hormones, Coagulation Factors, Others) · Oral Vaccines (Live Attenuated Vaccine, Inactivated Vaccine, Recombinant Vaccine, Others)
  • By ApplicationOncology · Hematology · Immunology · Endocrinology · Infectious Disease · Cardiovascular Disease · Others
  • By Distribution ChannelHospital Pharmacies · Retail Pharmacies · Online Pharmacies
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East & Africa
  • Published In29 Apr 2026
  • Report CodeCMI4396
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Drug Class
      • Market Snippet, By Application
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Recent Test Launches
    • Epidemiology
    • Merger, Acquisition, and Collaborations
    • Regulatory Scenario
    • Key Developments
    • PEST Analysis
  4. Global Therapeutic Proteins and Oral Vaccines Market, By Drug Class, 2021– 2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Therapeutic Proteins
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
      • Segment Trends
        • Growth Factors
        • Fusion Proteins
        • Monoclonal Antibodies
        • Hormones
        • Coagulation Factors
        • Others
    • Oral Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
      • Segment Trends
        • Live Attenuated Vaccine
        • Inactivated Vaccine
        • Recombinant Vaccine
        • Others
  5. Global Therapeutic Proteins and Oral Vaccines Market, By Application, 2021 – 2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Oncology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
      • Segment Trends
    • Hematology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
      • Segment Trends
    • Immunology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
      • Segment Trends
    • Endocrinology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
      • Segment Trends
    • Infectious Disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
      • Segment Trends
    • Cardiovascular Disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
      • Segment Trends
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
      • Segment Trends
  6. Global Therapeutic Proteins and Oral Vaccines Market, By Distribution Channel, 2021 – 2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
  7. Global Therapeutic Proteins and Oral Vaccines Market, By Region, 2021 – 2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2021 –2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth and By Application, 2021 –2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021–2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth and By Country,  2021 –2033, (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2021 –2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth and By Application, 2021 –2033, (US$ Mn)
      • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021–2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth and By Country,  2021 –2033, (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2021 –2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth and By Application, 2021 –2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021–2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth and By Country,  2021 –2033, (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Drug Class, 2021 –2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth and By Application, 2021 –2033, (US$ Mn)
      • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021–2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth and By Country,  2021 –2033, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Drug Class, 2021 –2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth and By Application, 2021 –2033, (US$ Mn)
      • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021–2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth and By Country,  2021 –2033, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2021 –2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth and By Application, 2021 –2033, (US$ Mn)
      • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021–2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth and By Country/Region, 2021 –2033, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape

    • Company Profiles
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Amgen, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Biogen, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Eli Lilly and Company
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • F. Hoffmann-La Roche AG
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Johnson and Johnson
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Merck & Co. Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Novo Nordisk A/S
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Pfizer, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Sanofi S.A.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Serum Institute of India Pvt. Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Emergent Biosolutions Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • TransAlgae
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • MigVax Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Lumen Bioscience, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
  9. Section

    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 36 market data tables and 26 figures on “Global Therapeutic Proteins and Oral Vaccines Market” – Global forecast to 2033